Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Amgen Inc (AMGN)  
$305.02 0.67 (0.22%) as of 4:30 Fri 6/7


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 585,690,000
Market Cap: 178.65(B)
Last Volume: 1,924,998 Avg Vol: 2,723,980
52 Week Range: $217.36 - $324.56
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:

    S&P COMPOSITE 1500     NASDAQ BIOTECHNOLOGY
    NASDAQ COMPOSITE     NASDAQ-100
    S&P 100     S&P 500
    NASDAQ NNM COMPOSITE

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  499
Guru Rank Value     : 3
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Amgen is a biotechnology company that focuses on discovering, developing, manufacturing and delivering human therapeutics. Co.'s principal products are Enbrel® (etanercept), Prolia® (denosumab), Otezla® (apremilast), XGEVA® (denosumab), Neulasta® (pegfilgrastim), Aranesp® (darbepoetin alfa), Repatha® (evolocumab), KYPROLIS® (carfilzomib) and Nplate® (romiplostim). Co. also markets a number of other products, including among other, MVASI® (bevacizumab-awwb), Vectibix® (panitumumab), KANJINTI® (trastuzumab-anns), EVENITY® (romosozumab-aqqg), EPOGEN® (epoetin alfa), BLINCYTO® (blinatumomab), AMGEVITA™ (adalimumab), Aimovig® (erenumab-aooe), Parsabiv® (etelcalcetide) and NEUPOGEN® (filgrastim).


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 2,117 2,117 23,771 31,503
Total Sell Value $662,802 $662,802 $6,471,520 $8,438,219
Total People Sold 1 1 3 6
Total Sell Transactions 1 1 4 8
End Date 2024-03-10 2023-12-08 2023-06-09 2022-06-09

   
Records found: 2206
  Page 27 of 89  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Patton Cynthia M SVP & CCO   •       •      –    2017-05-01 4 A $0.00 $0 D/D 984 24,560     -
   Hooper Anthony C EVP, Global Commercial Ops.   •       •      –    2017-05-01 4 A $0.00 $0 D/D 4,920 203,402     -
   Johnston Lori A SVP, HR   •       •      –    2017-05-01 4 A $0.00 $0 D/D 1,968 15,322     -
   Mcnamee Brian M EVP   •       •      –    2017-05-01 4 A $0.00 $0 D/D 3,444 102,516     -
   Bradway Robert A Chairman, CEO and President   •       •      –    2017-05-01 4 A $0.00 $0 D/D 14,760 396,242     -
   Harper Sean E EVP, Research & Development   •       •      –    2017-05-01 4 A $0.00 $0 D/D 4,551 60,496     -
   Graham Jonathan P SVP, Gen. Counsel & Secy.   •       •      –    2017-05-01 4 A $0.00 $0 D/D 3,075 50,619     -
   Sugar Ronald D Director   •       •      –    2017-05-01 4 A $0.00 $0 D/D 1,230 11,286     -
   Williams R Sanders Director   •       •      –    2017-05-01 4 A $0.00 $0 D/D 1,230 4,009     -
   Pelham Judith C Director   •       •      –    2017-05-01 4 A $0.00 $0 D/D 1,230 11,232     -
   Kullman Ellen Jamison Director   •       •      –    2017-05-01 4 A $0.00 $0 D/D 1,230 1,640     -
   Jacks Tyler Director   •       •      –    2017-05-01 4 A $0.00 $0 D/D 1,230 7,598     -
   Holley Charles M Director   •       •      –    2017-05-01 4 A $0.00 $0 D/D 1,230 1,230     -
   Herringer Frank C Director   •       •      –    2017-05-01 4 A $0.00 $0 D/D 1,230 32,011     -
   Hassan Fred Director   •       •      –    2017-05-01 4 A $0.00 $0 D/D 1,230 6,091     -
   Henderson Rebecca M Director   •       •      –    2017-05-01 4 A $0.00 $0 D/D 1,230 11,665     -
   De Carbonnel Francois Director   •       •      –    2017-05-01 4 D $163.32 $56,019 D/D (343) 19,498     -
   De Carbonnel Francois Director   •       •      –    2017-05-01 4 A $0.00 $0 D/D 1,230 19,841     -
   Eckert Robert Director   •       •      –    2017-05-01 4 A $0.00 $0 D/D 1,230 8,150     -
   Garland Greg C. Director   •       •      –    2017-05-01 4 A $0.00 $0 D/D 1,230 5,924     -
   Biondi Frank Director   •       •      –    2017-05-01 4 A $0.00 $0 D/D 1,230 36,635     -
   Baltimore David Director   •       •      –    2017-05-01 4 A $0.00 $0 D/D 1,230 34,859     -
   Santos Esteban EVP, Operations   •       •      –    2017-04-26 4 D $164.70 $31,458 D/D (191) 14,616     -
   Piacquad David SVP, Business Development   •       •      –    2017-04-26 4 D $164.70 $458,360 D/D (2,783) 32,549     -
   Such Annette Louise VP, Finance and CAO   •       •      –    2017-04-26 4 D $164.70 $7,247 D/D (44) 7,863     -

  2206 Records found
  Previous  20  21  22  23  24  25  26  27  28  29  Next   
  Page 27 of 89
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed